Cisplatin and Vinca Alkaloids: Antagonistic Effects in Cancer Cells
Author Information
Author(s): K. Lee, M. Tanaka, H. Kanamaru, T. Hashimura, I. Yamamoto, J. Konishi, F. Kuze
Primary Institution: Kyoto University School of Medicine
Hypothesis
Does cisplatin antagonize the cytotoxic effects of vinca alkaloids in human tumor cells?
Conclusion
Cisplatin antagonizes the cytotoxic effects of vinca alkaloids, and the interaction depends on the schedule of drug administration.
Supporting Evidence
- Cisplatin increased the cytotoxic effects of adriamycin, 5-fluorouracil, etoposide, and mitomycin C.
- Cisplatin antagonized the effects of vincristine, vindesine, vinblastine, and podophyllotoxin.
- The antagonism was observed in multiple cancer cell lines, including A549, HT29, NC65, and A431.
- The sequence of drug administration affected the level of antagonism observed.
Takeaway
When doctors give two types of cancer medicine together, one can make the other less effective, especially if they are given at the same time.
Methodology
The study used A549 lung cancer cells and other cell lines to test the effects of cisplatin combined with various cytotoxic agents in both simultaneous and sequential exposure.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Want to read the original?
Access the complete publication on the publisher's website